BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14743661)

  • 1. Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases.
    Kandt RS
    Neurol Clin; 2003 Nov; 21(4):983-1004. PubMed ID: 14743661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases.
    Kandt RS
    Neurol Clin; 2002 Nov; 20(4):941-64. PubMed ID: 12616676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallels between tuberous sclerosis complex and neurofibromatosis 1: common threads in the same tapestry.
    Gutmann DH
    Semin Pediatr Neurol; 1998 Dec; 5(4):276-86. PubMed ID: 9874855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.
    Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A
    Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hallazgos clínicos y epidemiológicos en la neurofibromatosis tipo 1 y el complejo esclerosis tuberosa en una serie de pacientes pediátricos].
    Cammarata-Scalisi F; Stock F; Velazco N; Silva GD; Lacruz-Rengel MA; Avendaño A
    Bol Med Hosp Infant Mex; 2018; 75(5):287-294. PubMed ID: 30250319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic thiol/disulphide homeostasis in children with neurofibromatosis type 1 and tuberous sclerosis.
    Incecik F; Avcıoğlu G; Erel Ö; Neşelioğlu S; Besen S; Altunbaşak S
    Acta Neurol Belg; 2019 Sep; 119(3):419-422. PubMed ID: 30820867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocutaneous syndromes: neurofibromatosis 1, neurofibromatosis 2, and tuberous sclerosis.
    Korf BR
    Curr Opin Neurol; 1997 Apr; 10(2):131-6. PubMed ID: 9146993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
    Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
    Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of genotypes and phenotypes in Chinese children with tuberous sclerosis complex.
    Bai D; Zhao J; Li L; Gao J; Wang X
    Sci China Life Sci; 2017 Jul; 60(7):763-771. PubMed ID: 28623545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From gene to disease; TSC1 and TSC2 genes and tuberous sclerosis complex].
    Verhoef S; Lindhout D; Halley DJ; van den Ouweland AM
    Ned Tijdschr Geneeskd; 2001 Oct; 145(40):1928-30. PubMed ID: 11675974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel mutation in TSC2 gene in pediatric patient with clinical diagnosis of tuberous sclerosis].
    Caicedo-Herrera G; Candelo E; Pachajoa H
    Arch Argent Pediatr; 2017 Oct; 115(5):e287-e290. PubMed ID: 28895704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birth Characteristics Among Children Diagnosed with Neurofibromatosis Type 1 and Tuberous Sclerosis.
    Tettamanti G; Mogensen H; Kampitsi CE; Nordgren A; Feychting M
    J Pediatr; 2021 Dec; 239():200-205.e2. PubMed ID: 34390698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberous sclerosis complex.
    Islam MP; Roach ES
    Handb Clin Neurol; 2015; 132():97-109. PubMed ID: 26564073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The results of recent research in neurocutaneous syndromes].
    Ohno K
    No To Hattatsu; 1998 Mar; 30(2):109-14. PubMed ID: 9545773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberous sclerosis complex: advances in diagnosis, genetics, and management.
    Schwartz RA; Fernández G; Kotulska K; Jóźwiak S
    J Am Acad Dermatol; 2007 Aug; 57(2):189-202. PubMed ID: 17637444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for TSC1 and TSC2 mutations using NGS in Greek children with tuberous sclerosis syndrome.
    Papadopoulou A; Dinopoulos A; Koutsodontis G; Pons R; Vorgia P; Koute V; Vratimos A; Zafeiriou D
    Eur J Paediatr Neurol; 2018 May; 22(3):419-426. PubMed ID: 29500070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigmentary disorders: update on neurofibromatosis-1 and tuberous sclerosis.
    Arbuckle HA; Morelli JG
    Curr Opin Pediatr; 2000 Aug; 12(4):354-8. PubMed ID: 10943816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurocutaneous syndromes: diagnosis and management for the primary care pediatrician.
    McIntosh C; Dehkharghani F
    J Ark Med Soc; 1984 Dec; 81(7):354-60. PubMed ID: 6240482
    [No Abstract]   [Full Text] [Related]  

  • 20. Unusual radiological presentation of tuberous sclerosis complex with leptomeningeal angiomatosis associated with a hypomorphic mutation in the TSC2 gene.
    Ramantani G; Niggemann P; Hahn G; Näke A; Fahsold R; Lee-Kirsch MA
    J Child Neurol; 2009 Mar; 24(3):333-7. PubMed ID: 19258292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.